Initial Submission definition

Initial Submission has the meaning given in Section 2.5(c).
View Source
Initial Submission has the meaning given in Section 2.5 [Fast Track Referee Process] in Schedule 20 [Dispute Resolution Procedure].
View Source
Initial Submission shall have the meaning ascribed thereto in Section 6.6.
View Source

Examples of Initial Submission in a sentence

  • The Initial Evaluation Report also will discuss the structuring and pricing implications raised by the information and responses received through the Initial Submission Phase.

  • If the FTRP Initiating Party fails to deliver its Initial Submission to the Referee and the FTRP Receiving Party within such five-Business Day period, the Dispute Notice shall be deemed to be withdrawn.

  • Timetable of Events 30th June 2006 to 31st March 20071 Initial Submission to GOWM 30.06.06 Voluntary/Community Sector Event, ▇▇▇▇▇▇▇▇ Showground 10.07.06 Informal feedback on draft June submission 14.07.06 Meeting of Staffordshire and GOWM Block Leads to discuss outcomes framework 20/21.07.06 Latest version of Outcomes Template/Key Drivers discussed at Block Leads Meeting 25.08.06 Deadline for High Level Outcomes to be sent to GOWM for sign off 5.09.06 Executive Board Away Day (Yarnfield).

  • Phase Deliverable Name Deliverable Initial Submission Date Deliverable Due Date Total Cost 1 - ECM Deliverable #1.01.

  • Initial Submission Date 22-Jun-21 Due Date 12-Jul-21 Attachment B Pricing $147,347.00 Performance Measure Successful completion and on-time delivery of the Training for Sys Admin with required supporting evidence.

  • The initial submission by Seller to each Lien Holder shall be on or before Initial Submission Deadline (§ 5.1 below).

  • The Independent Auditor shall forward a copy of each applicable party’s Initial Submission to Buyer and Seller, as applicable.

  • Initial Submission Date 27-Aug-20 Due Date 16-Sep-20 Attachment B Pricing $159,318.00 Performance Measure Successful completion and on-time delivery of the Requirements Specification Complete with required subcomponents.

  • Move Plans Section 12.4 (Move Plans) of Schedule 2 [Design and Not less than 18 months before each of the Target SFB Expansion Substantial Completion Date or the Target New Not less than 40 Business Days after receipt of the Authority’s # Plan/Schedule Name Relevant Project Agreement Provision(s) Deadline for Initial Submission of Plan(s)/ Schedule(s) Timing for Updates to Plan(s)/ Schedule(s) Construction Protocols] Tower Substantial Completion Date, as applicable comments on the preliminary draft 9.

  • Initial Submission Date 16-Apr-21 Due Date 6-May-21 Attachment B Pricing $294,694.00 Performance Measure Successful completion and on-time delivery of the CMS/CRM Test Cases with required subcomponents.


More Definitions of Initial Submission

Initial Submission has the meaning set forth in §10.2(a).
View Source
Initial Submission. Not later than 2 working days after access is no longer required 12. SUBMISSION FREQUENCY: As required
View Source
Initial Submission has the meaning set forth in (S)10.2(a). ------------------
View Source
Initial Submission. Not later than 10 working day following end of first period of performance
View Source

Related to Initial Submission

  • Planning Submission or “CAPS” or “Community Accountability Planning Submission” means the HSP Board approved planning document submitted by the HSP to the Funder. The form, content and scheduling of the Planning Submission will be identified by the Funder;

  • Selected submission means and refers to the submission sent to the City of Waco by the Selected Firm.

  • Initial application means the Application first provided to MFA on or before an Application Deadline to request an allocation of Tax Credits.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).